150 related articles for article (PubMed ID: 35795988)
1. ANP32E contributes to gastric cancer progression via NUF2 upregulation.
Zhu X; Zou Y; Wu T; Ni J; Tan Q; Wang Q; Zhang M
Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35795988
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of ANP32E is associated with poor prognosis of pancreatic cancer and promotes cell proliferation and migration through regulating β-catenin.
Zhang J; Lan Z; Qiu G; Ren H; Zhao Y; Gu Z; Li Z; Feng L; He J; Wang C
BMC Cancer; 2020 Nov; 20(1):1065. PubMed ID: 33148205
[TBL] [Abstract][Full Text] [Related]
3. Up-regulated ANP32E promotes the thyroid carcinoma cell proliferation and migration via activating AKT/mTOR/HK2-mediated glycolysis.
Huang J; Gao W; Liu H; Yin G; Duan H; Huang Z; Zhang Y
Gene; 2020 Aug; 750():144681. PubMed ID: 32304784
[TBL] [Abstract][Full Text] [Related]
4. ANP32e Binds Histone H2A.Z in a Cell Cycle-Dependent Manner and Regulates Its Protein Stability in the Cytoplasm.
Dijkwel Y; Hart-Smith G; Kurscheid S; Tremethick DJ
Mol Cell Biol; 2024; 44(2):72-85. PubMed ID: 38482865
[TBL] [Abstract][Full Text] [Related]
5. ANP32E is a histone chaperone that removes H2A.Z from chromatin.
Obri A; Ouararhni K; Papin C; Diebold ML; Padmanabhan K; Marek M; Stoll I; Roy L; Reilly PT; Mak TW; Dimitrov S; Romier C; Hamiche A
Nature; 2014 Jan; 505(7485):648-53. PubMed ID: 24463511
[TBL] [Abstract][Full Text] [Related]
6. Histone chaperone Anp32e removes H2A.Z from DNA double-strand breaks and promotes nucleosome reorganization and DNA repair.
Gursoy-Yuzugullu O; Ayrapetov MK; Price BD
Proc Natl Acad Sci U S A; 2015 Jun; 112(24):7507-12. PubMed ID: 26034280
[TBL] [Abstract][Full Text] [Related]
7. The histone chaperone Anp32e regulates memory formation, transcription, and dendritic morphology by regulating steady-state H2A.Z binding in neurons.
Stefanelli G; Makowski CE; Brimble MA; Hall M; Reda A; Creighton SD; Leonetti AM; McLean TAB; Zakaria JM; Baumbach J; Greer CB; Davidoff AM; Walters BJ; Murphy PJ; Zovkic IB
Cell Rep; 2021 Aug; 36(7):109551. PubMed ID: 34407406
[TBL] [Abstract][Full Text] [Related]
8. Silencing of NUF2 inhibits tumor growth and induces apoptosis in human hepatocellular carcinomas.
Liu Q; Dai SJ; Li H; Dong L; Peng YP
Asian Pac J Cancer Prev; 2014; 15(20):8623-9. PubMed ID: 25374179
[TBL] [Abstract][Full Text] [Related]
9. Anp32e, a higher eukaryotic histone chaperone directs preferential recognition for H2A.Z.
Mao Z; Pan L; Wang W; Sun J; Shan S; Dong Q; Liang X; Dai L; Ding X; Chen S; Zhang Z; Zhu B; Zhou Z
Cell Res; 2014 Apr; 24(4):389-99. PubMed ID: 24613878
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance and prospective molecular mechanism of NUF2 in gastric cancer exploration: A comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases.
Ge L; Sun Q; Xia L; Xu X
Medicine (Baltimore); 2022 Jul; 101(26):e29802. PubMed ID: 35777029
[TBL] [Abstract][Full Text] [Related]
11. ANP32E induces tumorigenesis of triple-negative breast cancer cells by upregulating E2F1.
Xiong Z; Ye L; Zhenyu H; Li F; Xiong Y; Lin C; Wu X; Deng G; Shi W; Song L; Yuan Z; Wang X
Mol Oncol; 2018 Jun; 12(6):896-912. PubMed ID: 29633513
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA NORAD promotes pancreatic cancer stem cell proliferation and self-renewal by blocking microRNA-202-5p-mediated ANP32E inhibition.
Ma YS; Yang XL; Liu YS; Ding H; Wu JJ; Shi Y; Jia CY; Lu GX; Zhang DD; Wang HM; Wang PY; Yu F; Lv ZW; Wang GR; Liu JB; Fu D
J Transl Med; 2021 Sep; 19(1):400. PubMed ID: 34551785
[TBL] [Abstract][Full Text] [Related]
13. SPAG5 contributes to the progression of gastric cancer by upregulation of Survivin depend on activating the wnt/β-catenin pathway.
Liu G; Liu S; Cao G; Luo W; Li P; Wang S; Chen Y
Exp Cell Res; 2019 Jun; 379(1):83-91. PubMed ID: 30904482
[TBL] [Abstract][Full Text] [Related]
14. HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway.
Geng H; Liu G; Hu J; Li J; Wang D; Zou S; Xu X
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396425
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of NUF2 inhibits tumor growth and induces apoptosis by regulating lncRNA AF339813.
Hu P; Shangguan J; Zhang L
Int J Clin Exp Pathol; 2015; 8(3):2638-48. PubMed ID: 26045769
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation mediated by H2A.Z via ANP32e-dependent inhibition of protein phosphatase 2A.
Shin H; He M; Yang Z; Jeon YH; Pfleger J; Sayed D; Abdellatif M
Biochim Biophys Acta Gene Regul Mech; 2018 May; 1861(5):481-496. PubMed ID: 29524612
[TBL] [Abstract][Full Text] [Related]
17. NUF2 as an anticancer therapeutic target and prognostic factor in breast cancer.
Lv S; Xu W; Zhang Y; Zhang J; Dong X
Int J Oncol; 2020 Dec; 57(6):1358-1367. PubMed ID: 33173994
[TBL] [Abstract][Full Text] [Related]
18. CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.
Zhang Y; Yin W; Cao W; Chen P; Bian L; Ni Q
Oncol Rep; 2019 Apr; 41(4):2471-2481. PubMed ID: 30816466
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous nuclear ribonucleoprotein K upregulates the kinetochore complex component NUF2 and promotes the tumorigenicity of colon cancer cells.
Sugimasa H; Taniue K; Kurimoto A; Takeda Y; Kawasaki Y; Akiyama T
Biochem Biophys Res Commun; 2015 Mar; 459(1):29-35. PubMed ID: 25701787
[TBL] [Abstract][Full Text] [Related]
20. Silencing of NUF2 inhibits proliferation of human osteosarcoma Saos-2 cells.
Fu HL; Shao L
Eur Rev Med Pharmacol Sci; 2016; 20(6):1071-9. PubMed ID: 27049259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
